T 1329/11 (Use of BNP-type peptides/ROCHE) of 19.11.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T132911.20151119
- Date of decision
- 19 November 2015
- Case number
- T 1329/11
- Petition for review of
- -
- Application number
- 05005356.0
- IPC class
- G01N 33/68
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- The use of BNP-type peptides and ANP-type peptides for assessing the risk of suffering from a cardiovascular complication as a consequence of volume overload
- Applicant name
- F. Hoffmann-La Roche AG
Roche Diagnostics GmbH - Opponent name
- B.R.A.H.M.S GmbH
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 133European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 13
- Keywords
- Oral submission by accompanying person (refused)
Sufficiency of disclosure - (no) - Catchword
- -
- Cited cases
- G 0004/95
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.